PathSensors Gets Expanded License to MIT Pathogen Detection Technology

Jul 09, 2020

|

NEW YORK — PathSensors said on Thursday that it has signed an agreement expanding its exclusive license to a Massachusetts Institute of Technology-developed pathogen detection technology to include clinical applications.

According to the Baltimore-based company, its first clinical application of the technology will be for SARS-CoV-2.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Breaking News

Featured White Papers

NGS-Based Target Capture for SARS-CoV-2 Detection and Characterization

Aug

19

Featured Webinar

Case Study: An IVD Manufacturer’s Experience Building a Complete Sample-to-Result Workflow

This webinar will present a case study from in vitro diagnostics developer SpeeDx on its experience building a complete sample-to-result workflow — encompassing instrumentation and data analysis software — for its qPCR-based ResistancePlus MG Mycoplasma genitalium assay.

Oct

09

Featured Webinar

Navigating the FDA's EUA Process for Diagnostics in the Present and Future: A Stakeholder Panel Discussion

As cases of COVID-19 continued to grow this spring and summer in the US, so too did the number of Emergency Use Authorizations from the FDA for clinical diagnostic tests aimed at detecting current and past infections.

Menu

PathSensors Gets Expanded License to MIT Pathogen Detection Technology

To read the full story....

Breaking News

Invitae Q2 Revenues Decrease 14 Percent but Beat Street Estimate

Fulgent Genetics Revenues More Than Double in Q2, Driven by COVID-19 Testing

GenMark Diagnostics Q2 Revenues More Than Double on COVID-19 Testing

Quanterix Q2 Revenues Down 3 Percent, Beating Wall Street Estimate

Luminex Q2 Revenues Rise 32 Percent on Pandemic-Related Sales

Qiagen Q2 Revenues Soar 16 Percent on Coronavirus Testing Product Sales

Featured White Papers

Case Study: An IVD Manufacturer’s Experience Building a Complete Sample-to-Result Workflow

Navigating the FDA's EUA Process for Diagnostics in the Present and Future: A Stakeholder Panel Discussion

What's Popular?

NHS Will Roll Out COVID-19 Tests From DnaNudge, Oxford Nanopore Across UK

Opko Health, Veracyte Pace Gainers as 360Dx Index Grow 13 Percent July

Facing 'Unfathomable' Demand, Quidel Ramps Up SARS-CoV-2 Test Production

Oxford Immunotec Q2 Revenues Slide 70 Percent on Coronavirus Impact

Antelope Dx Wins €2.2M Grant to Expand At-Home Diagnostic Technology

Sponsorships